Sanofi Research and Development Expenses 2010-2024 | SNY

Sanofi research and development expenses for the twelve months ending September 30, 2024 were $7.754B, a 8.5% increase year-over-year.

  • Sanofi annual research and development expenses for 2023 were $7.282B, a 3.06% increase from 2022.
  • Sanofi annual research and development expenses for 2022 were $7.065B, a 4.92% increase from 2021.
  • Sanofi annual research and development expenses for 2021 were $6.734B, a 6.63% increase from 2020.

Sanofi Research and Development Expenses 2010-2024 | SNY

  • Sanofi annual research and development expenses for 2023 were $7.282B, a 3.06% increase from 2022.
  • Sanofi annual research and development expenses for 2022 were $7.065B, a 4.92% increase from 2021.
  • Sanofi annual research and development expenses for 2021 were $6.734B, a 6.63% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$757B
Novo Nordisk (NVO)$483B
Johnson & Johnson (JNJ)$377.3B
AbbVie (ABBV)$354.3B
Merck (MRK)$255.9B
Novartis AG (NVS)$218.9B
AstraZeneca (AZN)$200.6B
Pfizer (PFE)$155.6B
Innoviva (INVA)$1.3B